首页> 外文期刊>mSphere >Genomewide Profiling of the Enterococcus faecalis Transcriptional Response to Teixobactin Reveals CroRS as an Essential Regulator of Antimicrobial Tolerance
【24h】

Genomewide Profiling of the Enterococcus faecalis Transcriptional Response to Teixobactin Reveals CroRS as an Essential Regulator of Antimicrobial Tolerance

机译:全基因组剖析粪肠球菌对Teixobactin的转录反应揭示CroRS作为抗微生物耐受性的重要调节剂。

获取原文
       

摘要

Teixobactin is a new antimicrobial of significant interest. It is active against a number of multidrug-resistant pathogens, including Staphylococcus aureus and Enterococcus faecalis , with no reported mechanisms of teixobactin resistance. However, historically, mechanisms of resistance always exist and arise upon introduction of a new antimicrobial into a clinical setting. Therefore, for teixobactin to remain effective long term, we need to understand how mechanisms of resistance could develop. Here we demonstrate that E. faecalis shows a remarkable intrinsic tolerance to high concentrations of teixobactin. This is of critical importance, as antimicrobial tolerance has been shown to precede the development of antimicrobial resistance. To identify potential pathways responsible for this tolerance, we determined the genomewide expression profile of E. faecalis strain JH2-2 in response to teixobactin using RNA sequencing. A total of 573 genes were differentially expressed (2.0-fold logsub2/sub change in expression) in response to teixobactin, with genes involved in cell wall biogenesis and division and transport/binding being among those that were the most upregulated. Comparative analyses of E. faecalis cell wall-targeting antimicrobial transcriptomes identified CroRS, LiaRS, and YclRK to be important two-component regulators of antimicrobial-mediated stress. Further investigation of CroRS demonstrated that deletion of croRS abolished tolerance to teixobactin and to other cell wall-targeting antimicrobials. This highlights the crucial role of CroRS in controlling the molecular response to teixobactin. IMPORTANCE Teixobactin is a new antimicrobial with no known mechanisms of resistance. Understanding how resistance could develop will be crucial to the success and longevity of teixobactin as a new potent antimicrobial. Antimicrobial tolerance has been shown to facilitate the development of resistance, and we show that E. faecalis is intrinsically tolerant to teixobactin at high concentrations. We subsequently chose E. faecalis as a model to elucidate the molecular mechanism underpinning teixobactin tolerance and how this may contribute to the development of teixobactin resistance.
机译:Teixobactin是一种具有重大意义的新型抗菌剂。它对多种耐多药病原体具有活性,包括金黄色葡萄球菌和粪肠球菌,尚无对teixobactin耐药的机制的报道。但是,从历史上看,耐药机制始终存在并在将新的抗菌素引入临床后出现。因此,要使teixobactin长期有效,我们需要了解耐药机制如何发展。在这里,我们证明粪肠球菌对高浓度的teixobactin具有显着的内在耐受性。这是至关重要的,因为已显示出抗菌素耐药性先于抗菌素耐药性的发展。为了确定造成这种耐受的潜在途径,我们使用RNA测序确定了粪肠球菌菌株JH2-2响应teixobactin的全基因组表达谱。总共573个基因对替沙宾菌素的反应差异表达(表达变化2.0倍log 2 ),其中涉及细胞壁生物发生,分裂和转运/结合的基因最多。上调。对粪肠球菌细胞壁靶向的抗菌转录组的比较分析表明,CroRS,LiaRS和YclRK是抗微生物介导的应激的重要两组分调节剂。对CroRS的进一步研究表明,删除croRS消除了对替ixobactin和其他靶向细胞壁的抗菌剂的耐受性。这突出了CroRS在控制对teixobactin的分子反应中的关键作用。重要说明Teixobactin是一种新型的抗菌药物,尚无耐药机制。理解抗药性如何发展对于作为新的有效抗菌剂的替ixobactin的成功与长寿至关重要。抗菌素的耐受性已被证明可以促进耐药性的发展,并且我们证明粪肠球菌对高浓度的teixobactin具有内在的耐受性。我们随后选择了粪肠球菌作为模型来阐明支撑​​替ixobactin耐受性的分子机制,以及这可能如何促进对替ixobactin抗性的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号